elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q45787936-D5BEC332-93E3-47A0-AA84-B60805271322
Q45787936-D5BEC332-93E3-47A0-AA84-B60805271322
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45787936-D5BEC332-93E3-47A0-AA84-B60805271322
The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EP
P2860
Q45787936-D5BEC332-93E3-47A0-AA84-B60805271322
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45787936-D5BEC332-93E3-47A0-AA84-B60805271322
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc12346b63d032810df499039f7416293e2e50e1
P2860
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.